Table 2.
Peak/Compound | Medium | UVmax (nm) | m/z [M + H]+ | Identity | Reference |
---|---|---|---|---|---|
1 | PC, PC-sh, CA-sh, WH, WH-sh | 220, 245, 292, 342 | 229.1 | Trioxsalen | [19] |
2 | WH-sh | 222, 279 | 277.2 | NK-A 17E-233II | [20] |
3 | CA, CA-sh | 221, 289, 310 | 211.1 | Agistatin D | [21] |
4 | CA, CA-sh | 205, 216, 222, 277 | 295.1 | Orsellide D | [22] |
5 | WH | 215, 306 | 311.3 | Orsellide C | [22] |
6 | CA, WH | 223, 275, 288 | 599.3 | Cyl-2 | [23] |
7 | CA | 223, 280 | 316.1 | Quinolinone B | [24] |
8 | CA | 227, 269, 334 | 282.1 | Harzianopyridone | [25] |
9 | PC, CA-sh, WH, WH-sh | 223, 261, 271, 281 | 282.2 | 2′-Deoxyribofuranosylguanine; 2N-Me | [26] |
UP1 | PC-sh | 221, 292 | 325.2 | n.k. | |
UP2 | PC, PC-sh, WH | 220, 275, 325, 360 | 273.1 | n.k. | |
UP3 | PC, PC-sh, WH, WH-sh | 218, 296, 364 | 289.1 | n.k. | |
UP4 | CA-sh, WH-sh | 232 | 279.3 | n.k. | |
UP5 | WH | 215, 303 | 327.3 | n.k. | |
UP6 | WH | 218, 297 | 312.2 | n.k. | |
UP7 | WH | 220, 266, 276, 287 | 393.1 | n.k. | |
UP8 | WH | 226 | 245.2 | n.k. | |
UP9 | WH-sh | 222, 280, 292, 305, 319 | 626.2 | n.k. |